Deletions in the 5' region of dystrophin and resulting phenotypes.
Open Access
- 1 November 1994
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 31 (11) , 843-847
- https://doi.org/10.1136/jmg.31.11.843
Abstract
Deletions in the dystrophin gene give rise to both Duchenne and Becker muscular dystrophies. Good correlation is generally found between the severity of the phenotype and the effect of the deletion on the reading frame: deletions that disrupt the reading frame result in a severe phenotype, while in frame deletions are associated with a milder disease course. Rare exceptions to this rule, mainly owing to frameshift mutations in the 5' region of the gene (in particular deletions involving exons 3 to 7) which are associated with a milder than expected phenotype, have been reported previously. In order to characterise better the relationship between genotype and phenotype as a result of mutations arising in the 5' region of the gene, we have studied a large cohort of patients with small in frame and out of frame deletions in the first 13 exons of the dystrophin gene. Fifty-five patients with a deletion in this area were identified; approximately one third of them had a phenotype different from that theoretically expected. Patients were divided into two groups: (1) patients with a severe clinical phenotype despite the presence of a small, in frame deletion and (2) patients with a mild phenotype and an out of frame deletion. Noticeable examples observed in the first group were Duchenne boys with a deletion of exon 5, of exon 3, and of exons 3-13. In the second group we observed several patients with an intermediate or Becker phenotype and out of frame deletions involving not only the usual exons 3-7 but also 5-7 and 3-6. These data indicate that a high proportion of patients with a deletion in the 5' end of the gene have a phenotype that is not predictable on the basis of the effect of the deletion on the reading frame. The N-terminus of dystrophin has at least one actin binding domain that might be affected by the small, in frame deletions in this area. The effect of the in frame deletions of exon 3, 5, and 3-13 on this domain might account for the severe phenotype observed in these patients. Other mechanisms, such as unexpected effect of the deletion on splicing behaviour, might, however, also be implicated in determining the phenotype outcome.Keywords
This publication has 28 references indexed in Scilit:
- Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.Journal of Medical Genetics, 1993
- Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?Human Molecular Genetics, 1993
- Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental abilityNeuromuscular Disorders, 1992
- Dystrophin or a “related protein” in Duchenne muscular dystrophy?Acta Neurologica Scandinavica, 1992
- Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophiesCell, 1990
- The interaction of actin with dystrophinFEBS Letters, 1990
- Frame-Shift Deletions in Patients with Duchenne and Becker Muscular DystrophyScience, 1988
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987
- Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophyMuscle & Nerve, 1982